|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Keratitis, Herpetic | |||||
| Ocular Herpes Simplex | |||||
| Herpes Simplex | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Herpes Zoster Ophthalmicus | |||||
| Keratitis | |||||
| 3 | More general conditions related to this trial | ||||
| Corneal Diseases | |||||
| DNA Virus Infections | |||||
| Eye Diseases | |||||
| Eye Infections | |||||
| Eye Infections, Viral | |||||
| Herpes Zoster | |||||
| Herpesviridae Infections | |||||
| Skin Diseases | |||||
| Skin Diseases, Infectious | |||||
| Skin Diseases, Viral | |||||
| Virus Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Stress | |||||
| Acyclovir | |||||
| 5 | Sponsors listed in this trial | ||||
| National Eye Institute (NEI) | |||||